3 more hospitals approved to use imported medicines

Writer: Chen Siqi  |  Editor: Liu Minxia  |  From: Shenzhen Daily  |  Updated: 2023-02-24

Three more Shenzhen hospitals were designated to implement the “Hong Kong and Macao Medicine and Equipment Connect” policy, the Guangdong Provincial Health Commission announced on its website Wednesday.

The commission announced that a total of 14 medical institutions in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) were newly included in the policy. The three institutions from Shenzhen are the Qianhai Shekou Free Trade Zone Hospital, Shenzhen Hyzen Hospital and C-MER (Shenzhen) Dennis Lam Eye Hospital.

The designated institutions can use imported drugs and medical devices that are urgently needed for clinical use and are available in the Hong Kong and Macao markets, or purchased by public hospitals in two cities.

As of Feb. 12, the Guangdong Provincial Medical Products Administration had approved the introduction of 23 types of imported medicines and 13 types of imported medical devices to the mainland. The medicines and devices were applied in 1,789 treatments.

The Hong Kong University Shenzhen Hospital was designated as the first hospital to pilot the policy, as per a work plan issued by the National Medical Products Administration in November 2020. Last August, the policy was later expanded and implemented in cities across the GBA.